{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:43:19Z","timestamp":1790239399011,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.3816\/clm.2003.s.005","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T21:03:09Z","timestamp":1221166989000},"page":"S23-S29","source":"Crossref","is-referenced-by-count":52,"special_numbering":"S1","title":["The Implications of Anemia in Multiple Myeloma"],"prefix":"10.3816","volume":"4","author":[{"given":"Moshe","family":"Mittelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2003.s.005_bib1","first-page":"29","article-title":"Multiple myeloma: review of 869 cases","volume":"50","author":"Kyle","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"10.3816\/CLM.2003.s.005_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJM199402173300709","article-title":"The treatment of multiple myeloma","volume":"330","author":"Alexanian","year":"1994","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.s.005_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/asheducation-2001.1.157","article-title":"Multiple myeloma","author":"Dalton","year":"2001","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.3816\/CLM.2003.s.005_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/asheducation-2002.1.214","article-title":"Multiple myeloma","author":"Anderson","year":"2002","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.3816\/CLM.2003.s.005_bib5","first-page":"522","article-title":"Guideline: diagnosis and management of multiple myeloma","volume":"155","author":"Samson","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-9343(62)90262-0","article-title":"Studies of the anemia of multiple myeloma","volume":"33","author":"Cline","year":"1962","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.s.005_bib7","series-title":"Wintrobe's Clinical Hematology","first-page":"2631","article-title":"Multiple Myeloma","author":"Foerster","year":"1999"},{"key":"10.3816\/CLM.2003.s.005_bib8","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJM199006143222402","article-title":"Erythropoietin treatment of anemia associated with multiple myeloma","volume":"322","author":"Ludwig","year":"1990","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.s.005_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/stem.5530110203","article-title":"Recombinant human erythropoietin and the anemia of multiple myeloma","volume":"11","author":"Barlogie","year":"1993","journal-title":"Stem Cells"},{"key":"10.3816\/CLM.2003.s.005_bib10","first-page":"1201","article-title":"Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin","volume":"32","author":"Mittelman","year":"1996","journal-title":"Isr J Med Sci"},{"key":"10.3816\/CLM.2003.s.005_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V84.4.997.997","article-title":"Recombinant human erythropoietin and the anemia of cancer","volume":"84","author":"Spivak","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib12","first-page":"61","article-title":"The anemia of chronic disease","volume":"20","author":"Lee","year":"1983","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2003.s.005_bib13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0959-8049(93)90032-B","article-title":"Increased blood cell destruction during vigorous regeneration of bone marrow after intensive chemotherapy for non- Hodgkin lymphoma","volume":"29A","author":"Maruyama","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2003.s.005_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI116178","article-title":"Increased plasma viscosity as a reason for inappropriate erythropoietin formation","volume":"91","author":"Singh","year":"1993","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2003.s.005_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archinte.1969.00300140040009","article-title":"Blood volume and hematocrit value in macroglobulinemia and myeloma","volume":"123","author":"Kopp","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2003.s.005_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0025-7125(16)30340-6","article-title":"Anemia of chronic disease","volume":"76","author":"Sears","year":"1992","journal-title":"Med Clin North Am"},{"key":"10.3816\/CLM.2003.s.005_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1749-6632.1974.tb14450.x","article-title":"Anemia of cancer","volume":"230","author":"Berlin","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.3816\/CLM.2003.s.005_bib18","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1182\/blood.V78.5.1198.1198","article-title":"Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia","volume":"78","author":"Klein","year":"1991","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.1997.tb01677.x","article-title":"Clinical results of recombinant erythropoietin in transfusion-dependent patients with refractory multiple myeloma: role of cytokines and monitoring of erythropoiesis","volume":"58","author":"Musto","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/10428199509059639","article-title":"Erythropoiesis and erythropoietin in multiple myeloma","volume":"18","author":"Beguin","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.s.005_bib21","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199006143222401","article-title":"Decreased erythropoietin response in patients with the anemia of cancer","volume":"322","author":"Miller","year":"1990","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.s.005_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood.V80.3.841.841","article-title":"Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders","volume":"80","author":"Mittelman","year":"1992","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1365-2141.1992.tb06939.x","article-title":"Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production","volume":"82","author":"Beguin","year":"1992","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000204376","article-title":"Recombinant erythropoietin in myelodysplastic syndromes: whom to treat and how? More questions than answers","volume":"90","author":"Mittelman","year":"1993","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib25","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood.V86.12.4446.bloodjournal86124446","article-title":"Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response","volume":"86","author":"Cazzola","year":"1995","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0609.1992.tb00031.x","article-title":"Erythropoietin response in anaemic patients with multiple myeloma and other lymphoid malignancies infiltrating the bone marrow","volume":"49","author":"Ariad","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2141.1992.tb02976.x","article-title":"Responsiveness of bone marrow erythroid progenitors (CFU-E and BFU-E) to recombinant human erythropoietin in vitro in multiple myeloma","volume":"81","author":"Aoki","year":"1992","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V77.6.1228.1228","article-title":"Erythropoietin is both a mitogen and a survival factor","volume":"77","author":"Spivak","year":"1991","journal-title":"Blood"},{"issue":"suppl 2","key":"10.3816\/CLM.2003.s.005_bib29","first-page":"13","article-title":"The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue","volume":"34","author":"Cella","year":"1997","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2003.s.005_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000203625","article-title":"Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia","volume":"98","author":"Mittelman","year":"1997","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib31","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","article-title":"Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group","volume":"15","author":"Glaspy","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib32","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","article-title":"Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group","volume":"16","author":"Demetri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/annonc\/mdg167","article-title":"Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes","volume":"14","author":"Cella","year":"2003","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib34","series-title":"Cancer nursing: a comprehensive textbook","first-page":"894","article-title":"Alterations in energy: the sensation of fatigue","author":"Piper","year":"1991"},{"key":"10.3816\/CLM.2003.s.005_bib35","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","article-title":"The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study","volume":"37","author":"Silverberg","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.3816\/CLM.2003.s.005_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/radiology.201.2.8888257","article-title":"Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study","volume":"201","author":"Dubray","year":"1996","journal-title":"Radiology"},{"issue":"suppl 7","key":"10.3816\/CLM.2003.s.005_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0037-1963(01)90125-8","article-title":"The negative impact of anemia on radiotherapy and chemoradiation outcomes","volume":"38","author":"Shasha","year":"2001","journal-title":"Semin Hematol"},{"key":"10.3816\/CLM.2003.s.005_bib38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation measured myeloma cell mass with presenting clinical features, response to treatment and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"issue":"suppl 3","key":"10.3816\/CLM.2003.s.005_bib39","first-page":"1","article-title":"New approaches to the treatment of cancer-related anemia: Introduction","volume":"21","author":"Silver","year":"1994","journal-title":"Semin Oncol"},{"issue":"suppl 3","key":"10.3816\/CLM.2003.s.005_bib40","first-page":"16","article-title":"Immunologic aspects of blood transfusion","volume":"21","author":"Klein","year":"1994","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib41","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1200\/JCO.2000.18.14.2755","article-title":"Cost of outpatient blood transfusion in cancer patients","volume":"18","author":"Cremieux","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","article-title":"Erythropoietin","volume":"77","author":"Krantz","year":"1991","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib43","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJM199105093241907","article-title":"Erythropoietin","volume":"324","author":"Erslev","year":"1991","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.s.005_bib44","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1073\/pnas.82.22.7580","article-title":"Cloning and expression of the human erythropoietin gene","volume":"82","author":"Lin","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2003.s.005_bib45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJM198907203210305","article-title":"Treatment of the anemia of progressive renal failure with recombinant human erythropoietin","volume":"321","author":"Eschbach","year":"1989","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.3816\/CLM.2003.s.005_bib46","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0959-8049(05)80282-5","article-title":"Erythropoietin treatment of chronic anaemia of cancer","volume":"29A","author":"Ludwig","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2003.s.005_bib47","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/archinte.1995.00430190059008","article-title":"Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial","volume":"155","author":"Garton","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2003.s.005_bib48","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood.V87.7.2675.bloodjournal8772675","volume":"87","author":"Osterborg","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2141.2001.02715.x","article-title":"Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma","volume":"113","author":"Dammacco","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2003.s.005_bib50","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-2008-1065126","article-title":"Erythropoietin beim multiplen myeloma (erythropoietin in multiple myeloma)","volume":"115","author":"Pescherstorfer","year":"1990","journal-title":"Dtsch Med Wschr"},{"key":"10.3816\/CLM.2003.s.005_bib51","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0959-8049(93)90033-C","article-title":"Erythropoietin treatment of anaemia associated with lymphoproliferative disorders","volume":"29A","author":"Molica","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2003.s.005_bib52","first-page":"705","article-title":"Improvement of anemia in patients with multiple myeloma by recombinant erythropoietin: A multicenter study","volume":"22","author":"Bessho","year":"1994","journal-title":"Exp Hematol"},{"key":"10.3816\/CLM.2003.s.005_bib53","first-page":"59","article-title":"Therapy of anemia in patients with multiple myeloma","volume":"22","author":"Adam","year":"1995","journal-title":"Acta Med Austriaca"},{"key":"10.3816\/CLM.2003.s.005_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01696618","article-title":"Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myeloma","volume":"70","author":"Silvestris","year":"1995","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2003.s.005_bib55","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib56","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V84.4.1056.1056","article-title":"Prediction of response to erythropoietin treatment in chronic anemia of cancer","volume":"84","author":"Ludwig","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib57","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1182\/blood.V89.12.4248","article-title":"Use of recombinant human erythropoietin outside the setting of uremia","volume":"89","author":"Cazzola","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib58","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2002-06-1767","article-title":"Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology","volume":"100","author":"Rizzo","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/10428199809068565","article-title":"The role of recombinant erythropoietin for the treatment of anemia in multiple myeloma","volume":"29","author":"Musto","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.s.005_bib60","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0889-8588(18)30143-6","article-title":"Clinical application of recombinant erythropoietin in myelodysplasia","volume":"8","author":"Mittelman","year":"1994","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2003.s.005_bib61","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.s.005_bib62","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200202143460711","article-title":"Drug-induced autoimmune red-cell aplasia","volume":"346","author":"Bunn","year":"2002","journal-title":"N Engl J Med"},{"issue":"2 suppl 3","key":"10.3816\/CLM.2003.s.005_bib63","first-page":"9","article-title":"The relationship of erythropoietin and iron metabolism to red blood cell production in humans","volume":"21","author":"Adamson","year":"1994","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib64","series-title":"Better Blood Transfusion","author":"National Health Services Executive","year":"1998"},{"issue":"suppl","key":"10.3816\/CLM.2003.s.005_bib65","first-page":"391b","article-title":"Erythropoietin has an antimyeloma effect- A clinical observation supported by animal studies","volume":"100","author":"Mittelman","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.s.005_bib66","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.081275298","article-title":"Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models","volume":"98","author":"Mittelman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2003.s.005_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.annonc.a058423","article-title":"Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors","volume":"4","author":"Ludwig","year":"1993","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib68","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2001.19.11.2875","article-title":"Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing","volume":"19","author":"Gabrilove","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.s.005_bib69","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/0006-291X(90)90510-T","article-title":"Expression of the erythropoietin receptor on a human myeloma cell line","volume":"170","author":"Okuno","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3816\/CLM.2003.s.005_bib70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.301.6753.667-a","article-title":"Effect of erythropoietin in patients with myeloma","volume":"301","author":"Rogers","year":"1990","journal-title":"BMJ"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152696551170046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152696551170046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T02:42:29Z","timestamp":1588905749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152696551170046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":70,"alternative-id":["S152696551170046X"],"URL":"https:\/\/doi.org\/10.3816\/clm.2003.s.005","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}